CNTA

Centessa Pharmaceuticals
CNTA

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$47
74% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Wolfe Research
Wolfe Research
Rudy Li
100% 1-yr CNTA win rate
24 Feb ‘26 6 days ago
Truist Securities
Truist Securities
Danielle Brill
100% 1-yr CNTA win rate
29 Jan ‘26 1 month ago
Oppenheimer
Oppenheimer
Kostas Biliouris
0% 1-yr CNTA win rate
10 Dec ‘25 2 months ago